Viraferonpeg and pulmonary embolism Patient Reports February 11, 2012



Viraferonpeg Side Effects Report #5850705-0
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 13, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: prothrombin level decreased, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5863861-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 21, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, prothrombin level decreased, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5875886-4
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 29, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, cough, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5878625-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 05, 2008. Female patient, 65 years of age, weighting 163.1 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: asthenia, prothrombin level decreased, pulmonary embolism What is  pulmonary embolism, weight decreased. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #5518652-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 05, 2007. Male patient, 51 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5528915-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 16, 2007. Male patient, 50 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5535117-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 28, 2007. Male patient, 47 years of age, weighting 231.5 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, OGAST, MEPRONIZINE, STRESAM, EFFERALGAN. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5592525-0
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 09, 2008. Male patient, 47 years of age, weighting 231.5 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, OGAST, MEPRONIZINE, STRESAM, EFFERALGAN. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4758147-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 22, 2005. Male patient, 43 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism, suicidal ideation. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #4780378-X
Viraferonpeg side effect was reported by a Physician from FRANCE on Sept 16, 2005. Male patient, 43 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: abnormal behaviour, pulmonary embolism What is  pulmonary embolism, suicidal ideation. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5486047-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 04, 2007. Male patient, 39 years of age, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: disease recurrence, oedema peripheral, pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient died.

Viraferonpeg Side Effects Report #5512804-2
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 29, 2007. Male patient, 39 years of age, weighting 174.2 lb, was diagnosed with hepatitis c What is  hepatitis c and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: arrhythmia What is  arrhythmia, disease recurrence, lung disorder, oedema peripheral, pulmonary embolism What is  pulmonary embolism, vomiting. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, PREVISCAN, ZOLOFT, OXAZEPAM. Patient died.

Viraferonpeg Side Effects Report #5203534-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 28, 2006. Male patient, 38 years of age, was diagnosed with hepatitis c What is  hepatitis c, anaemia and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: anaemia, axillary vein thrombosis, pelvic venous thrombosis, platelet count abnormal, protein s deficiency, pulmonary embolism What is  pulmonary embolism, pyrexia, thrombophlebitis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, SUSTIVA, COMBIVIR, ARANESP. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5191028-5
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 05, 2006. Male patient, 38 years of age, was diagnosed with hepatitis c What is  hepatitis c, anaemia and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: anaemia, asthenia, axillary vein thrombosis, pelvic venous thrombosis, platelet count increased, protein total decreased, pulmonary embolism What is  pulmonary embolism, pyrexia, thrombophlebitis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, ARANESP, SUSTIVA, COMBIVIR. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #5919071-6
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on Oct 06, 2008. Female patient, 31 years of age, weighting 116.8 lb, was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Viraferonpeg